Abstract
P-304 Triple class refractory multiple myeloma: eficacy of the new immunotherapies and new unmet medical need
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have